Browsing OU - Faculty and Staff Publications by series "PLoS ONE 10(9): e0139237"
Now showing items 1-1 of 1
-
CXCR2 Inhibition Combined with Sorafenib Improved Antitumor and Antiangiogenic Response in Preclinical Models of Ovarian Cancer
(PLos One, 2015-09-28)Antiangiogenic therapy is important for the treatment of gynecological cancer. However, the therapeutic benefit derived from these treatments is transient, predominantly due to the selective activation of compensatory ...